• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖儿童血清循环中天门冬氨酸的水平升高。

Increased serum circulating asprosin levels in children with obesity.

机构信息

Department of Pediatrics, Istanbul Training and Education Hospital, İstanbul, Turkey.

出版信息

Pediatr Int. 2020 Apr;62(4):467-476. doi: 10.1111/ped.14176.

DOI:10.1111/ped.14176
PMID:32003085
Abstract

BACKGROUND

Childhood obesity is a growing and significant problem worldwide. Asprosin is a novel adipokine that is significantly associated with glucose and insulin production in the liver during fasting. In the present study, we aimed to demonstrate whether there would be differences between obese, overweight, and normal weight children in terms of serum asprosin levels.

METHODS

Forty-four children with obesity, 54 overweight children, and 60 normal weight children were compared in terms of serum asprosin levels and other anthropometric, biochemical, and hormonal parameters that are associated with being overweight and with obesity.

RESULTS

Serum asprosin levels were found to be significantly different between groups: 70.903 ± 17.49 ng/mL, 79.744 ± 29.54 ng/mL, and 106.293 ± 122.69 ng/mL in normal weight, overweight, and obese children respectively. Post-hoc analysis revealed that the asprosin level was significantly higher in obese children compared with normal weight children (P = 0.009). Additionally, asprosin was found to be a predictor of obesity in multiple regression analysis.

CONCLUSION

Our study is the first to demonstrate increased levels of asprosin in obese children compared with normal weight children. Further studies are needed to demonstrate the role of asprosin in the etiology of childhood obesity, as well as other diseases that might be associated with effects of asprosin.

摘要

背景

儿童肥胖是全球日益严重且重大的问题。天门冬氨酸是一种新型脂肪因子,在空腹时与肝脏中葡萄糖和胰岛素的产生有显著关联。本研究旨在证明肥胖、超重和正常体重儿童的血清天门冬氨酸水平是否存在差异。

方法

比较了 44 名肥胖儿童、54 名超重儿童和 60 名正常体重儿童的血清天门冬氨酸水平以及与超重和肥胖相关的其他人体测量、生化和激素参数。

结果

血清天门冬氨酸水平在各组之间存在显著差异:正常体重、超重和肥胖儿童的血清天门冬氨酸水平分别为 70.903±17.49ng/mL、79.744±29.54ng/mL 和 106.293±122.69ng/mL。事后分析显示,肥胖儿童的天门冬氨酸水平明显高于正常体重儿童(P=0.009)。此外,多元回归分析显示天门冬氨酸是肥胖的预测因子。

结论

本研究首次证明肥胖儿童的天门冬氨酸水平高于正常体重儿童。需要进一步研究来证明天门冬氨酸在儿童肥胖病因学以及可能与天门冬氨酸作用相关的其他疾病中的作用。

相似文献

1
Increased serum circulating asprosin levels in children with obesity.肥胖儿童血清循环中天门冬氨酸的水平升高。
Pediatr Int. 2020 Apr;62(4):467-476. doi: 10.1111/ped.14176.
2
The association of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents.血浆饥饿素与韩国儿童和青少年人体测量学和代谢参数的关系。
Front Endocrinol (Lausanne). 2024 Oct 3;15:1452277. doi: 10.3389/fendo.2024.1452277. eCollection 2024.
3
Asprosin serum levels and glucose homeostasis in children with obesity.肥胖儿童的血清淀粉酶原水平与葡萄糖稳态。
Cytokine. 2021 Jun;142:155477. doi: 10.1016/j.cyto.2021.155477. Epub 2021 Mar 1.
4
Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity.与膳食相关的内脂素血清水平受肥胖儿童胰岛素抵抗和空腹血糖受损的影响。
Front Endocrinol (Lausanne). 2022 Jan 6;12:805700. doi: 10.3389/fendo.2021.805700. eCollection 2021.
5
Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.GLP-1 受体激动剂对 2 型糖尿病正常体重或超重/肥胖患者 asparagin 水平的影响。
Medicine (Baltimore). 2022 Oct 28;101(43):e31334. doi: 10.1097/MD.0000000000031334.
6
Decreased Circulating Levels of Asprosin in Obese Children.肥胖儿童循环中阿普斯灵水平降低。
Horm Res Paediatr. 2019;91(4):271-277. doi: 10.1159/000500523. Epub 2019 Jun 18.
7
A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination.一项在体检人群中研究血清 asporsin 水平与 MAFLD 之间关系的研究。
Sci Rep. 2024 May 15;14(1):11170. doi: 10.1038/s41598-024-62124-w.
8
Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.肥胖症儿童的天门冬氨酸蛋白原升高与非酒精性脂肪性肝病有关。
World J Pediatr. 2021 Aug;17(4):394-399. doi: 10.1007/s12519-021-00444-x. Epub 2021 Aug 9.
9
Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity.血清阿普索林浓度升高与肥胖儿童的胰岛素抵抗有关。
Ann Nutr Metab. 2019;75(4):205-212. doi: 10.1159/000503808. Epub 2019 Nov 27.
10
Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.儿童和青少年肥胖及胰岛素抵抗中β-促细胞生成素浓度的特征分析。
Pediatr Diabetes. 2016 Feb;17(1):53-60. doi: 10.1111/pedi.12233. Epub 2014 Nov 21.

引用本文的文献

1
The Role of Adipokines and Gene Polymorphisms in the Development of Obesity- Induced Depression.脂肪因子和基因多态性在肥胖诱导的抑郁症发生中的作用
Curr Obes Rep. 2025 Jul 28;14(1):62. doi: 10.1007/s13679-025-00652-w.
2
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health.对脂肪因子阿朴脂蛋白的病理生理学见解:生殖健康领域中一种新出现的脂肪因子。
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09975-4.
3
The correlation between serum asprosin and type 2 diabetic patients with obesity in the community.
社区中血清阿扑脂蛋白与肥胖的2型糖尿病患者之间的相关性。
Front Endocrinol (Lausanne). 2025 May 5;16:1535668. doi: 10.3389/fendo.2025.1535668. eCollection 2025.
4
Lack of correlation between asprosin serum levels and hyperphagic behavior in subjects with prader-Willi Syndrome.普拉德-威利综合征患者血清阿普洛辛水平与摄食亢进行为之间缺乏相关性。
J Endocrinol Invest. 2025 Apr;48(4):979-986. doi: 10.1007/s40618-024-02511-2. Epub 2024 Dec 5.
5
Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial.运动和饮食干预对腹型肥胖男性中 asparagin、瘦素和脂代谢的影响:一项随机对照试验。
Sci Rep. 2024 Nov 15;14(1):28109. doi: 10.1038/s41598-024-79853-7.
6
The association of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents.血浆饥饿素与韩国儿童和青少年人体测量学和代谢参数的关系。
Front Endocrinol (Lausanne). 2024 Oct 3;15:1452277. doi: 10.3389/fendo.2024.1452277. eCollection 2024.
7
Asprosin: its function as a novel endocrine factor in metabolic-related diseases.阿朴啡肽:作为代谢相关疾病新型内分泌因子的功能。
J Endocrinol Invest. 2024 Aug;47(8):1839-1850. doi: 10.1007/s40618-024-02360-z. Epub 2024 Apr 3.
8
Circulating levels of asprosin in children with obesity: a systematic review and meta-analysis.肥胖儿童中 asparsin 的循环水平:系统评价和荟萃分析。
BMC Endocr Disord. 2024 Mar 13;24(1):36. doi: 10.1186/s12902-024-01565-w.
9
Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose browning in mice.人视黄醇结合蛋白 4 通过诱导脂肪细胞自噬抑制白色脂肪棕色化参与肥胖的发病机制。
Int J Obes (Lond). 2024 Jul;48(7):913-922. doi: 10.1038/s41366-024-01495-6. Epub 2024 Feb 19.
10
Salivary and serum asprosin hormone levels in the 2018 EFP/AAP classification of periodontitis stages and body mass index status: a case-control study.唾液和血清 asprosin 激素水平在 2018 年牙周炎分期和体质指数状况的 EFP/AAP 分类中的研究:病例对照研究。
Clin Oral Investig. 2024 Jan 13;28(1):91. doi: 10.1007/s00784-024-05494-9.